Sort
17,828 grants matching “crispr”
Transgenic Mouse, ICSI & IVF Core
$224,314Stefan Moisyadi · University Of Hawaii At Manoa · P30 · FY2023 · GM
Development of a Tool Kit for Human Filarial Transfection
$224,250Thomas R Unnasch · University Of South Florida · R21 · FY2018 · AI
Global Predictions and Tests of Hematopoietic Regulation
$224,250Ross C Hardison · Pennsylvania State University, The · R56 · FY2014 · DK
The impact of p53 variants on liver disease
$224,249Thibaut Barnoud · Medical University Of South Carolina · P20 · FY2024 · GM
Determining the role for lncRNAs in controlling inflammation
$224,159Susan Carpenter · University Of California Santa Cruz · R21 · FY2019 · AI
Development of a human cellular TBK1 model for drug discovery in ALS
$224,119Sandy Hinckley · Quralis Corporation · R43 · FY2019 · NS
Neurobiological significance of Aqp4 stop codon readthrough
$224,101Darshan Sapkota · University Of Texas Dallas · R00 · FY2023 · AG
Development of functional genomic technologies in mice
$224,101Aki Ushiki · Washington University · R00 · FY2025 · HG
mRNA Alternative Splicing Regulatory Networks in the Specification of Cortical Interneuron Subtypes
$224,100Melissa McKenzie Campbell · University Of California, San Diego · R00 · FY2025 · MH
mRNA Alternative Splicing Regulatory Networks in the Specification of Cortical Interneuron Subtypes
$224,100Melissa McKenzie Campbell · University Of California, San Diego · R00 · FY2024 · MH
Core B - Cell Engineering and Manufacturing Facility
$224,099Donald L Siegel · University Of Pennsylvania · P01 · FY2025 · CA
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies
$224,024Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Developmental causes of syndromic Thrombocytopenia and co-morbidities
$223,920Alexa Burger · University Of Colorado Denver · R01 · FY2024 · DK
Novel insulin-sensitizing NASH/diabetes drugs.
$223,817Timothy R Peterson · Bioio, Llc · R42 · FY2019 · DK
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
$223,801David Sung-Wen Yu · Cleveland Clinic Lerner Com-Cwru · U54 · FY2025 · CA
Tools for Creating a Super-Resolution Interaction Map of Subcellular Dynamics in Living Bacteria Cells
$223,768Julie Biteen · University Of Michigan At Ann Arbor · R21 · FY2018 · GM
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
$223,750Benjamin Elison Gewurz · Brigham And Women'S Hospital · R21 · FY2023 · AI
Systematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell Lysis
$223,750Benjamin Elison Gewurz · Brigham And Women'S Hospital · R21 · FY2024 · AI
Genome engineering for a novel post-reproductive genetic screen for increased longevity
$223,500Patrick C. Phillips · University Of Oregon · R21 · FY2024 · AG
Detailed analysis of Cryptosporidium non-coding gene expression
$223,357Jessica C Kissinger · University Of Georgia · R21 · FY2020 · AI
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
$223,181Matthew L Freedman · Dana-Farber Cancer Inst · R21 · FY2015 · CA
Discovering the mechanisms of-action-mistargeted anti-cancer agents
$223,174Jason Sheltzer · Yale University · R01 · FY2024 · CA
Microfluidic platforms to generate 'off-the-shelf' fratricide-resistant CAR T cells for T-cell malignancies
$223,162Sunil Sudhir Raikar · Emory University · R21 · FY2021 · CA
A CRISPR-Cas9 screen to identify genetic modifiers of APP/BACE-1 interactions
$223,140Subhojit Roy · University Of Wisconsin-Madison · R21 · FY2016 · AG
Development of viral vector mediated CRISPR/Cas9 editing of the prairie vole oxytocin receptor gene
$223,125Larry J Young · Emory University · R21 · FY2017 · MH